blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0303250

EP0303250 - Novel pyrazinoxide compound of NF-1616-904 and a pharmaceutical composition containing the same and a process for its preparation [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  17.02.1994
Database last updated on 25.09.2024
Most recent event   Tooltip17.02.1994No opposition filed within time limitpublished on 06.04.1994 [1994/14]
Applicant(s)For all designated states
OTSUKA PHARMACEUTICAL CO., LTD.
9, Kandatsukasa-cho 2-chome Chiyoda-ku
Tokyo 101-0048 / JP
[N/P]
Former [1989/07]For all designated states
OTSUKA PHARMACEUTICAL CO., LTD.
9, Kandatsukasa-cho 2-chome
Chiyoda-ku Tokyo 101 / JP
Inventor(s)01 / Nakano, Yoshimasa
37-2, Aza Higashino Kasagi Aizumicho
Itano-gun Tokushima-ken / JP
02 / Sugawara, Michiharu
1-79, Aza Shimozao Shingirai Kitajimacho
Itano-gun Tokushima-ken / JP
03 / Uetsuki, Setsuyoshi
17-1, Sakosanbancho
Tokushima-shi / JP
04 / Izawa, Taketoshi
65-6, Aza Minamikawamukai Hiroshima Matsushigecho
Itano-gun Tokushima-ken / JP
05 / Kawaguchi, Tomoyuki
463-10, Kagasuno Kawauchicho
Tokushima-shi / JP
06 / Wada, Akira
463-10, Kagasuno Kawauchicho
Tokushima-shi / JP
[1989/07]
Representative(s)Hansen, Bernd, et al
Hoffmann Eitle Patent- und Rechtsanwälte Postfach 81 04 20
81904 München / DE
[N/P]
Former [1989/17]Hansen, Bernd, Dr.rer.nat., et al
Hoffmann, Eitle & Partner Patentanwälte Postfach 81 04 20
D-81904 München / DE
Former [1989/07]Hansen, Bernd, Dr. Dipl.-Chem.
Hoffmann, Eitle & Partner Patent- und Rechtsanwälte, Postfach 81 04 20
D-81904 München / DE
Application number, filing date88112999.310.08.1988
[1989/07]
Priority number, dateJP1987020153711.08.1987         Original published format: JP 20153787
[1989/07]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP0303250
Date:15.02.1989
Language:EN
[1989/07]
Type: A3 Search report 
No.:EP0303250
Date:11.07.1990
Language:EN
[1990/28]
Type: B1 Patent specification 
No.:EP0303250
Date:14.04.1993
Language:EN
[1993/15]
Search report(s)(Supplementary) European search report - dispatched on:EP22.05.1990
ClassificationIPC:C07D403/06, C12P1/02
[1989/07]
CPC:
C07D403/06 (EP,KR,US); A61P1/16 (EP); A61P13/02 (EP);
A61P15/00 (EP); A61P37/06 (EP); A61P43/00 (EP);
A61P9/00 (EP); A61P9/08 (EP); A61P9/10 (EP);
C12P17/165 (EP,US) (-)
Designated contracting statesCH,   DE,   ES,   FR,   GB,   IT,   LI,   NL,   SE [1989/07]
TitleGerman:Pyrazinoxid-Verbindung aus NF-1616-904, diese enthaltende Arzneimittelzubereitung und Verfahren zu ihrer Herstellung[1989/07]
English:Novel pyrazinoxide compound of NF-1616-904 and a pharmaceutical composition containing the same and a process for its preparation[1989/07]
French:Dérivés pyrazinoxyde de NF-1616-904, composition pharmaceutique le contenant et son procédé de préparation[1989/07]
Biological materialThis application mentions deposited biological material, check the file for details
Examination procedure27.11.1990Examination requested  [1991/04]
27.06.1991Despatch of a communication from the examining division (Time limit: M04)
30.10.1991Reply to a communication from the examining division
22.07.1992Despatch of communication of intention to grant (Approval: Yes)
07.10.1992Communication of intention to grant the patent
17.12.1992Fee for grant paid
17.12.1992Fee for publishing/printing paid
Opposition(s)15.01.1994No opposition filed within time limit [1994/14]
Fees paidRenewal fee
30.08.1990Renewal fee patent year 03
30.08.1991Renewal fee patent year 04
28.08.1992Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]EP0181152  (FUJISAWA PHARMACEUTICAL CO [JP])
 [A]  - CHEMICAL ABSTRACTS, vol. 95, 1981, page 738, abstract no. 7743q, Columbus, Ohio, US; T. KANMERA et al.: "Cyclic peptides. IX. Asymmetric hydrogenation of alpha,beta-dehydroamino acid residue in cyclodipeptides and preparation of optically pure alpha-amino acids", & INT. J. PEPT. PROTEIN RES. 1980, 16(4), 280-90
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.